These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 36114528)

  • 41. Association of ideal cardiovascular health metrics and incident type 2 diabetes mellitus among an urban population of Iran: One decade follow up in the Tehran Lipid and Glucose Study.
    Asgari S; Masrouri S; Hosseinpour-Niazi S; Moslehi N; Azizi F; Hadaegh F
    J Diabetes Investig; 2022 Oct; 13(10):1711-1722. PubMed ID: 35588067
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Low-carbohydrate diet and cardiovascular diseases in Iranian population: Tehran Lipid and Glucose Study.
    Farhadnejad H; Asghari G; Teymoori F; Tahmasebinejad Z; Mirmiran P; Azizi F
    Nutr Metab Cardiovasc Dis; 2020 Apr; 30(4):581-588. PubMed ID: 32008914
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Early mortality and cardiovascular disease, varied association with body mass index and its changes in insulin-treated diabetes: a nationwide study.
    Lee YB; Kim B; Park J; Kim M; Choi MS; Kim G; Jin SM; Hur KY; Han K; Kim JH
    Int J Obes (Lond); 2021 Nov; 45(11):2482-2489. PubMed ID: 34344992
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The association between transition from metabolically healthy obesity to metabolic syndrome, and incidence of cardiovascular disease: Tehran lipid and glucose study.
    Hosseinpanah F; Tasdighi E; Barzin M; Mahdavi M; Ghanbarian A; Valizadeh M; Azizi F
    PLoS One; 2020; 15(9):e0239164. PubMed ID: 32947607
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association of Dietary Diabetes Risk Reduction Score With Risk of Cardiovascular Diseases in the Iranian Population: Tehran Lipid and Glucose Study.
    Asghari G; Farhadnejad H; Teymoori F; Emamat H; Shahrzad MK; Habibi-Moeini AS; Mirmiran P; Azizi F
    Heart Lung Circ; 2022 Jan; 31(1):101-109. PubMed ID: 34176740
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of weight change on specific-cause mortality among middle-aged Japanese individuals.
    Saito I; Konishi M; Iso H; Inoue M; Tsugane S
    J Epidemiol Community Health; 2009 Jun; 63(6):447-54. PubMed ID: 19221112
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hearing loss increases all-cause and cardiovascular mortality in middle-aged and older Chinese adults: the Dongfeng-Tongji Cohort Study.
    Zhang H; Fang Q; Li M; Yang L; Lai X; Wang H; He M; Wang Z; Kong W; Zhang X
    Environ Sci Pollut Res Int; 2023 Jul; 30(32):78394-78407. PubMed ID: 37268810
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Weight changes from early to middle adulthood and cardiometabolic multimorbidity later in life among middle-aged and older adults: a retrospective cohort study from the NHANES 1999-2018.
    Zhao F; Zhao Q; Wang H; Wang K; Kong S; Ma P; Wang X
    Front Endocrinol (Lausanne); 2024; 15():1306551. PubMed ID: 38440787
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of diabesity phenotype on cardiovascular diseases, major cardiovascular events and all-cause mortality.
    Mehrabani-Zeinabad K; Haghighatdoost F; Mohammadifard N; Najafian J; Sadeghi M; Boshtam M; Roohafza H; Nouri F; Aune D; Sarrafzadegan N
    Sci Rep; 2023 Jul; 13(1):11266. PubMed ID: 37438573
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Shadow of diabetes over cardiovascular disease: comparative quantification of population-attributable all-cause and cardiovascular mortality.
    Bozorgmanesh M; Hadaegh F; Sheikholeslami F; Ghanbarian A; Azizi F
    Cardiovasc Diabetol; 2012 Jun; 11():69. PubMed ID: 22704235
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Obesity, weight change, and mortality in older adults with metabolic abnormalities.
    Dong SY; Wang ML; Li ZB; Dong Z; Liu YQ; Lu RJ; Li JM; Tang R
    Nutr Metab Cardiovasc Dis; 2018 Jul; 28(7):749-755. PubMed ID: 29807768
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Weight change across adulthood in relation to all cause and cause specific mortality: prospective cohort study.
    Chen C; Ye Y; Zhang Y; Pan XF; Pan A
    BMJ; 2019 Oct; 367():l5584. PubMed ID: 31619383
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Weight Change and Mortality from Cardiovascular Diseases: The Japan Collaborative Cohort Study.
    Okada C; Kubota Y; Eshak ES; Cui R; Tamakoshi A; Iso H;
    J Atheroscler Thromb; 2021 Jan; 28(1):25-33. PubMed ID: 32378530
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association between weight change and incidence of cardiovascular disease events and mortality among adults with type 2 diabetes: a systematic review of observational studies and behavioural intervention trials.
    Strelitz J; Lawlor ER; Wu Y; Estlin A; Nandakumar G; Ahern AL; Griffin SJ
    Diabetologia; 2022 Mar; 65(3):424-439. PubMed ID: 34859263
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Weight change and all-cause, cancer and cardiovascular disease mortality in Japanese men and women: the Japan Public Health Center-Based Prospective Study.
    Nanri A; Mizoue T; Takahashi Y; Noda M; Inoue M; Tsugane S;
    Int J Obes (Lond); 2010 Feb; 34(2):348-56. PubMed ID: 19918251
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Objectively Assessed Weight Change and All-Cause Mortality among Community-Dwelling Older People.
    Alharbi T; Ryan J; Freak-Poli R; Gasevic D; Scali J; Ritchie K; Ancelin ML; Owen AJ
    Nutrients; 2022 Jul; 14(14):. PubMed ID: 35889940
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Obesity Paradox and Risk of Mortality Events in Chronic Kidney Disease Patients: A Decade of Follow-up in Tehran Lipid and Glucose Study.
    Mohebi R; Simforoosh A; Tohidi M; Azizi F; Hadaegh F
    J Ren Nutr; 2015 Jul; 25(4):345-50. PubMed ID: 25680526
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cardiovascular effects of weight loss in old adults with overweight/obesity according to change in skeletal muscle mass.
    Cai X; Liu M; Xu X; Zhang S; Huang R; Wang P; He L; Chen Z; Liu Z; Zhou Y; Guo Y; Zhuang X; Liao X
    J Cachexia Sarcopenia Muscle; 2024 Feb; 15(1):342-351. PubMed ID: 38108096
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ideal cardiovascular health status and risk of cardiovascular disease and all-cause mortality: over a decade of follow-up in the Tehran lipid and glucose study.
    Hadaegh F; Hosseinpour-Niazi S; Deravi N; Hasheminia M; Moslehi N; Toreyhi H; Azizi F
    Front Cardiovasc Med; 2022; 9():898681. PubMed ID: 35990976
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab).
    Barr EL; Zimmet PZ; Welborn TA; Jolley D; Magliano DJ; Dunstan DW; Cameron AJ; Dwyer T; Taylor HR; Tonkin AM; Wong TY; McNeil J; Shaw JE
    Circulation; 2007 Jul; 116(2):151-7. PubMed ID: 17576864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.